7 unknown, 1 completed. 3 Not applicable, 3 Phase 3, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 3 |
| Phase 3 | 3 | Unknown 3 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Stemirna Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors Neoantigen mRNA Personalised Cancer vaccine - Advanced Malignant Solid Tumors | Not applicable | Unknown | Stemirna Therapeutics | 20 | 2023-07-20 | 2023-07-18 |
| A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2; - Immunogenicity, Safety | Phase 2 / Phase 3 | Unknown | Stemirna Therapeutics | 800 | 2023-06-20 | 2023-06-20 |
| mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2., Pfizer(BNT162b2);SARS-Cov-2. - Immunogenicity, Safety | Phase 3 | Unknown | Stemirna Therapeutics | 600 | 2022-10-19 | 2023-01-17 |
| New Generation mRNA Booster Vaccine Against Emerging VOCs SW-BIC-213, SARS-Cov-2 Vaccina(Vero Cell ) Inactivated - Immunogenicity, Efficacy | Phase 3 | Unknown | Stemirna Therapeutics | 2000 | 2022-10-01 | 2023-04-12 |
| A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors Neoantigen mRNA Personalised Cancer SW1115C3 - Solid Tumor | Phase 1 | Unknown | Stemirna Therapeutics | 30 | 2022-03-18 | 2022-10-17 |
| A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above COVID-19 mRNA vaccine - COVID-19 Pandemic | Phase 1 / Phase 2 | Completed | Stemirna Therapeutics | 480 | 2021-12-03 | 2022-12-28 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer Personalized mRNA Tumor Vaccine - Esophageal Cancer, Non Small Cell Lung Cancer | Not applicable | Unknown | Stemirna Therapeutics | 24 | 2019-10-18 | 2023-04-13 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms Personalized mRNA Tumor Vaccine - Advanced Esophageal Squamous Carcinoma, Gastric Adenocarcinoma | Not applicable | Unknown | Changhai Hospital | 24 | 2018-05-01 | 2019-02-26 |
COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1)
Laos (3) · China (2) · Australia (1) · Austria (1)
Mayfong Mayxay, doctor (3) · Mayfong Mayxay, professor (1) · Xianbao Zhan, Dr. (1)